CAS 150683-30-0 MFCD09837707-Tolvaptan 托伐普坦 -LabNovo

SMILES: CC1=CC(=CC=C1C(=O)N1CCC[C@@H](O)C2C=C(Cl)C=CC1=2)NC(=O)C1=CC=CC=C1C

Mol. Formula	C26H25ClN2O3
Mol. Weight	448.948

信息真实价格透明资金保障专业采购外包团队在线服务

品牌质保精细包装现货库存一流品牌服务

[2]. Inomata T.
[3]. Vaduganathan M, Gheorghiade M, Pang PS, Konstam MA, Zannad F, Swedberg K, Grinfeld L, Burnett JC Jr, Krasa HB, Zimmer C, Blair J, Ouyang J, Maggioni AP; EVEREST investigators.
[4]. Y Yamamura et al. OPC-41061, a Highly Potent Human Vasopressin V2-Receptor Antagonist: Pharmacological Profile and Aquaretic Effect by Single and Multiple Oral Dosing in Rats. J. Pharmacol.
[5]. RW Schrier et al. Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist, for Hyponatremia. N Engl J Med 2006, 355, 2099-2112.
Efficacy of oral tolvaptan in acute heart failure patients with hypotension and renal impairment.
Efficacy of oral tolvaptan in acute heart failure patients with hypotension and renal impairment.
Exp. Ther. 1998, 287(3), 860-867.
Exp. Ther. 1998, 287(3), 860-867.
Hyponatremia in critical care patients: Frequency, outcome, characteristics, and treatment with the vasopressin V(2)-receptor an

相关产品推荐